Sara Lambiase
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Sara Lambiase has a total of 83 co-authors. Here are the top co-authors by number of shared publications:
Mauro Esposito
Centro di Referenza Nazionale per l'Analisi e Studio di Correlazione tra Ambiente, Animale e Uomo, IZS Mezzogiorno, Via Salute 2, 80055 Portici, Italy
7 shared publicationsPasquale Gallo
Centro di Referenza Nazionale per l'Analisi e Studio di Correlazione tra Ambiente, Animale e Uomo, IZS Mezzogiorno, Via Salute 2, 80055 Portici, Italy
6 shared publications- Mauro Esposito
Zoo‐Prophylactic Institute of Southern Italy Portici Italy
5 shared publications - Francesco Paolo Serpe
Department of Food Security Coordination, Istituto Zooprofilattico Sperimentale del Mezzogiorno, 80055 Portici, NA, Italy
4 shared publications Filomena Fiorito
Dipartimento di Medicina Veterinaria e Produzioni animali, Università degli Studi di Napoli Federico II, Naples, Italy
3 shared publications- Filomena Fiorito
Department of Veterinary Medicine and Animal Production, University of Naples Federico II, Naples, Italy
3 shared publications
Latest Publications
- Open Access
The Use of Antimicrobials in Animal Husbandry as a Potential Factor for the Increased Incidence of Colorectal Cancer: Food Safety and Kinetics in a Murine Model
The aim of this research was to investigate the effects of the prolonged use of the broad-spectrum antimicrobial widely used in animal husbandry. By means of a mouse model, a translational study was carried out on immunocompetent mice (with a complete immune system). This study highlighted the effect of antimicrobial residues taken in with food on the growth time of cancer and on alterations to the gut microbiota. This project considered the fight against antimicrobial resistance from a One Health perspectivethrough collaboration between human medicine and veterinary medicine. Regarding food safety, antimicrobial residues in products of animal origin are rarely detected; they therefore constitute a negligible factor in determining colorectal cancer.
Open AccessThe Use of Antimicrobials in Animal Husbandry as a Potential Factor for the Increased Incidence of Colorectal Cancer: Food Safety and Kinetics in a Murine Model
The aim of this research was to investigate the effects of the prolonged use of the broad-spectrum antimicrobial widely used in animal husbandry. By means of a mouse model, a translational study was carried out on immunocompetent mice (with a complete immune system). This study highlighted the effect of antimicrobial residues taken in with food on the growth time of cancer and on alterations to the gut microbiota. This project considered the fight against antimicrobial resistance from a One Health perspectivethrough collaboration between human medicine and veterinary medicine. Regarding food safety, antimicrobial residues in products of animal origin are rarely detected; they therefore constitute a negligible factor in determining colorectal cancer.
- Open Access
- 1 January 2025
- Published by Wiley in Dermatologic Therapy
- Vol. 2025 (1)
Efficacy and Safety of Glycopyrronium Bromide 1% Cream in Axillary and Extra‐Axillary Primary Hyperhidrosis: A Real‐Life Two‐Center Experience on 68 Subjects
Introduction: Primary hyperhidrosis (PH) is a common disorder affecting approximately 1% of the general population, characterized by focal sweating in excess of that required for normal temperature regulation without any associated condition. It is an embarrassing and disabling condition with a great impact on patients’ quality of life. Glycopyrronium bromide (GPB) 1% cream is a recently authorized topical pharmacological treatment for primary axillary PH. Although the efficacy of this treatment for axillary hyperhidrosis is well established, there are no clinical data regarding both efficacy and safety of GPB 1% cream when used in other body areas such as palm, plantar, and craniofacial regions (out‐of‐label use). Materials and Methods: In this study, the real‐life experience of two Italian tertiary center care dermatology clinics for treatment of PH with GPB 1% cream for both axillary and extra‐axillary localizations has been reported. Patients suffering from PH were treated for 12 weeks. The treatment of the affected areas with GPB 1% cream consisted of once‐daily application for 4 weeks (T4), followed by a reduced frequency of application over the following 8 weeks (T12). Main efficacy outcomes included assessment of change in the 4‐point Hyperhidrosis Disease Severity Scale (HDSS) and the 36‐point Hyperhidrosis Quality of Life Index (HidroQoL); axillary PH patients were also assessed for change in the 4‐item Axillary Daily Sweating Diary (ASDD). Safety of use was assessed at both T4 and T12, through anamnestic collection of symptoms and direct patient observation. Results: Patients with PH evaluated were 68 (39 female and 29 males with a mean age of 40 ± 16.0 years). Thirty‐one subjects (45%) suffered from axillary PH, 10 subjects (15%) had multiple localizations (axilla and palmoplantar and axilla and craniofacial), 13 subjects showed only palmar involvement (19%), and 14 subjects experienced only craniofacial PH (21%). All subjects but 5 (7%) completed the 12‐week treatment period. HDSS score before treatment was 3.54 ± 0.53, HidroQoL 27.874 ± 2.238.7, and ASDD ( n = 31) 13.66 ± 1.5. The mean HDSS value was reduced significantly to 1.1 ± 0.45 at T4 ( p = 0.001) and to 1.2 ± 0.50 at T12; the overall percentage of HDSS good responder patients (patients experiencing a reduction in HDSS of at least two points = reduction in sweating between 50% and 75% from baseline value) was 53% at T4 and 43% at T12, and the other patients were considered mild responders. HidroQoL was reduced to 8.18 ± 1.83(T4) and 9.05 ± 0.78 (T12) ( p = 0.001). As expected, GPB 1% cream was highly effective in subjects with axillary PH considering the reduction in ASDD score to 2.1 ± 0.57 and 2.2 ± 0.65 at T4 and T12, respectively ( p = 0.001). Considering the different localizations of hyperhidrosis separately, at T4, the percentage of patients experiencing a reduction in HDSS of at least two points was 76%, 30%, 55%, and 50% for axillary, palmar, craniofacial, and multiple localizations, respectively. At T12, the percentage of patients experiencing a reduction in HDSS of at least two points was 70%, 26%, 40%, and 35% for axillary, palmar, craniofacial, and multiple localizations, respectively. At T4, the treatment was effective also for multiple localizations (axilla and palmoplantar and axilla and craniofacial) and craniofacial PH, although the efficacy was lower in comparison with axillary PH ( p = 0.01 for both comparisons) but higher than palmar hyperhidrosis ( p = 0.05 at least). At T12, the treatment confirms its efficacy for multiple localizations and craniofacial PH, although with less efficacy than axillary PH ( p = 0.001) and without any difference between body sites. The treatment was safe, and no adverse events emerged other than those expected. Two patients with craniofacial PH dropped out due to adverse events (transient blurred vision and urinary hesitancy). Conclusion: Our real‐life experience with GPB 1% cream confirmed that the treatment is very effective and safe in axillary PH. Moderate–good efficacy was observed also for PH involving craniofacial and multiple localizations (axilla and palmoplantar and axilla and craniofacial), while less efficacy was found in the treatment of palmar hyperhidrosis. The use of GPB 1% cream in the craniofacial region should be carried out with caution due to possible adverse events.
- 1 January 2025
- Published by Wiley in Dermatologic Therapy
- Vol. 2025 (1)
Open AccessEfficacy and Safety of Glycopyrronium Bromide 1% Cream in Axillary and Extra‐Axillary Primary Hyperhidrosis: A Real‐Life Two‐Center Experience on 68 Subjects
Introduction: Primary hyperhidrosis (PH) is a common disorder affecting approximately 1% of the general population, characterized by focal sweating in excess of that required for normal temperature regulation without any associated condition. It is an embarrassing and disabling condition with a great impact on patients’ quality of life. Glycopyrronium bromide (GPB) 1% cream is a recently authorized topical pharmacological treatment for primary axillary PH. Although the efficacy of this treatment for axillary hyperhidrosis is well established, there are no clinical data regarding both efficacy and safety of GPB 1% cream when used in other body areas such as palm, plantar, and craniofacial regions (out‐of‐label use). Materials and Methods: In this study, the real‐life experience of two Italian tertiary center care dermatology clinics for treatment of PH with GPB 1% cream for both axillary and extra‐axillary localizations has been reported. Patients suffering from PH were treated for 12 weeks. The treatment of the affected areas with GPB 1% cream consisted of once‐daily application for 4 weeks (T4), followed by a reduced frequency of application over the following 8 weeks (T12). Main efficacy outcomes included assessment of change in the 4‐point Hyperhidrosis Disease Severity Scale (HDSS) and the 36‐point Hyperhidrosis Quality of Life Index (HidroQoL); axillary PH patients were also assessed for change in the 4‐item Axillary Daily Sweating Diary (ASDD). Safety of use was assessed at both T4 and T12, through anamnestic collection of symptoms and direct patient observation. Results: Patients with PH evaluated were 68 (39 female and 29 males with a mean age of 40 ± 16.0 years). Thirty‐one subjects (45%) suffered from axillary PH, 10 subjects (15%) had multiple localizations (axilla and palmoplantar and axilla and craniofacial), 13 subjects showed only palmar involvement (19%), and 14 subjects experienced only craniofacial PH (21%). All subjects but 5 (7%) completed the 12‐week treatment period. HDSS score before treatment was 3.54 ± 0.53, HidroQoL 27.874 ± 2.238.7, and ASDD ( n = 31) 13.66 ± 1.5. The mean HDSS value was reduced significantly to 1.1 ± 0.45 at T4 ( p = 0.001) and to 1.2 ± 0.50 at T12; the overall percentage of HDSS good responder patients (patients experiencing a reduction in HDSS of at least two points = reduction in sweating between 50% and 75% from baseline value) was 53% at T4 and 43% at T12, and the other patients were considered mild responders. HidroQoL was reduced to 8.18 ± 1.83(T4) and 9.05 ± 0.78 (T12) ( p = 0.001). As expected, GPB 1% cream was highly effective in subjects with axillary PH considering the reduction in ASDD score to 2.1 ± 0.57 and 2.2 ± 0.65 at T4 and T12, respectively ( p = 0.001). Considering the different localizations of hyperhidrosis separately, at T4, the percentage of patients experiencing a reduction in HDSS of at least two points was 76%, 30%, 55%, and 50% for axillary, palmar, craniofacial, and multiple localizations, respectively. At T12, the percentage of patients experiencing a reduction in HDSS of at least two points was 70%, 26%, 40%, and 35% for axillary, palmar, craniofacial, and multiple localizations, respectively. At T4, the treatment was effective also for multiple localizations (axilla and palmoplantar and axilla and craniofacial) and craniofacial PH, although the efficacy was lower in comparison with axillary PH ( p = 0.01 for both comparisons) but higher than palmar hyperhidrosis ( p = 0.05 at least). At T12, the treatment confirms its efficacy for multiple localizations and craniofacial PH, although with less efficacy than axillary PH ( p = 0.001) and without any difference between body sites. The treatment was safe, and no adverse events emerged other than those expected. Two patients with craniofacial PH dropped out due to adverse events (transient blurred vision and urinary hesitancy). Conclusion: Our real‐life experience with GPB 1% cream confirmed that the treatment is very effective and safe in axillary PH. Moderate–good efficacy was observed also for PH involving craniofacial and multiple localizations (axilla and palmoplantar and axilla and craniofacial), while less efficacy was found in the treatment of palmar hyperhidrosis. The use of GPB 1% cream in the craniofacial region should be carried out with caution due to possible adverse events.
- Open Access
Paralytic Shellfish Poisoning (PSP) Toxins in Bivalve Molluscs from Southern Italy Analysed by Liquid Chromatography Coupled with High-Resolution Mass Spectrometry (UHPLC-HRMS/MS)
A new method for simultaneous determination by liquid chromatography coupled with high resolution mass spectrometry (UHPLC-HRMS/MS) of 14 paralytic shellfish poisoning toxins (PSP), that is, Saxitoxin, Neosaxitoxin, Gonyautoxins and their respective variants, in bivalve molluscs, is herein described. The samples were extracted by acetic acid solution, then analysed by UHPLC coupled with a Q-Exactive Orbitrap Plus high resolution mass spectrometer, by electrospray ionization mode (ESI) with no further clean up step. The analysis was carried out by monitoring both the exact mass of the molecular precursor ion of each compound (in mass scan mode, resolution at 70,000 FWHM) and its respective fragmentation patterns (two product ions) with mass accuracy greater than 5 ppm. The analytical performance of the method was evaluated calculating trueness, as mean recoveries of each biotoxin, between 77.8% and 111.9%, a within-laboratory reproducibility (RSDR) between 3.6% and 12.2%, the specificity, the linearity of detector response, and the ruggedness for slight changes The results of the validation study demonstrate this method fits for the purposes of the official control of PSP toxins in molluscs. The results of two years of monitoring in local mussel farms are also reported, showing that no significant concerns for food safety in the monitored productions.
Open AccessParalytic Shellfish Poisoning (PSP) Toxins in Bivalve Molluscs from Southern Italy Analysed by Liquid Chromatography Coupled with High-Resolution Mass Spectrometry (UHPLC-HRMS/MS)
A new method for simultaneous determination by liquid chromatography coupled with high resolution mass spectrometry (UHPLC-HRMS/MS) of 14 paralytic shellfish poisoning toxins (PSP), that is, Saxitoxin, Neosaxitoxin, Gonyautoxins and their respective variants, in bivalve molluscs, is herein described. The samples were extracted by acetic acid solution, then analysed by UHPLC coupled with a Q-Exactive Orbitrap Plus high resolution mass spectrometer, by electrospray ionization mode (ESI) with no further clean up step. The analysis was carried out by monitoring both the exact mass of the molecular precursor ion of each compound (in mass scan mode, resolution at 70,000 FWHM) and its respective fragmentation patterns (two product ions) with mass accuracy greater than 5 ppm. The analytical performance of the method was evaluated calculating trueness, as mean recoveries of each biotoxin, between 77.8% and 111.9%, a within-laboratory reproducibility (RSDR) between 3.6% and 12.2%, the specificity, the linearity of detector response, and the ruggedness for slight changes The results of the validation study demonstrate this method fits for the purposes of the official control of PSP toxins in molluscs. The results of two years of monitoring in local mussel farms are also reported, showing that no significant concerns for food safety in the monitored productions.
- 6 September 2024
- Published by Springer Nature in Environmental Science and Pollution Research
- Vol. 31 (43) , 55695-55707
Levels of PCDD/Fs, PCBs, metals and rare earth elements in eggs and vegetables from areas with different environmental contamination impacts in the Campania region (Southern Italy)
Studying the links between environmental pollution and the levels of contamination in food is an important challenge to ensure human health. Matched samples of eggs from free-range hens and vegetables were analysed to investigate the bioaccumulation of PCDD/Fs, PCBs, metals and rare earth elements. Only two egg samples resulted above the limit fixed for PCDD/Fs and the action level set for DL-PCBs. The highest concentrations were found in the eggs from an area situated in a big city affected by strong urbanisation. Although eggs and vegetables were subjected to the same environmental pollution, the PCDD/F and PCB bioaccumulation that occurred in the eggs was much higher than those in vegetables (p < 0.01). In vegetables, the highest PCDD/F and PCB concentrations were found in lettuce and potatoes grown on contaminated soil. Higher bioaccumulation of Fe and Zn occurred in eggs compared to vegetables; La, Pr, Nd, Sm and Eu were found only in lettuce samples. The results of this study may provide important data useful in the risk assessment of human exposure through diet in accidents involving dangerous chemicals. Furthermore, the estimated weekly intakes calculated for PCDD/Fs and PCBs highlighted that, although vegetables accumulate very low concentrations of these contaminants, they contribute more than eggs to human exposure. Graphical Abstract
- 6 September 2024
- Published by Springer Nature in Environmental Science and Pollution Research
- Vol. 31 (43) , 55695-55707
Levels of PCDD/Fs, PCBs, metals and rare earth elements in eggs and vegetables from areas with different environmental contamination impacts in the Campania region (Southern Italy)
Studying the links between environmental pollution and the levels of contamination in food is an important challenge to ensure human health. Matched samples of eggs from free-range hens and vegetables were analysed to investigate the bioaccumulation of PCDD/Fs, PCBs, metals and rare earth elements. Only two egg samples resulted above the limit fixed for PCDD/Fs and the action level set for DL-PCBs. The highest concentrations were found in the eggs from an area situated in a big city affected by strong urbanisation. Although eggs and vegetables were subjected to the same environmental pollution, the PCDD/F and PCB bioaccumulation that occurred in the eggs was much higher than those in vegetables (p < 0.01). In vegetables, the highest PCDD/F and PCB concentrations were found in lettuce and potatoes grown on contaminated soil. Higher bioaccumulation of Fe and Zn occurred in eggs compared to vegetables; La, Pr, Nd, Sm and Eu were found only in lettuce samples. The results of this study may provide important data useful in the risk assessment of human exposure through diet in accidents involving dangerous chemicals. Furthermore, the estimated weekly intakes calculated for PCDD/Fs and PCBs highlighted that, although vegetables accumulate very low concentrations of these contaminants, they contribute more than eggs to human exposure. Graphical Abstract
- 27 September 2022
- Published by Elsevier in Chemosphere
- Vol. 309 (Pt 1) , 136602
Bioaccumulation of PCDD/Fs and PCBs in free-range hens: Congener fingerprints and biotransfer factors
- 27 September 2022
- Published by Elsevier in Chemosphere
- Vol. 309 (Pt 1) , 136602
Bioaccumulation of PCDD/Fs and PCBs in free-range hens: Congener fingerprints and biotransfer factors
- 1 November 2021
- Published by Elsevier in Marine Pollution Bulletin
- Vol. 172, 112825
Oyster Crassostrea gigas, a good model for correlating viral and chemical contamination in the marine environment
- 1 November 2021
- Published by Elsevier in Marine Pollution Bulletin
- Vol. 172, 112825
Oyster Crassostrea gigas, a good model for correlating viral and chemical contamination in the marine environment
- 1 November 2021
- Published by Elsevier in Science of The Total Environment
- Vol. 794, 148504
Dioxins and dioxin-like PCBs in buffalo milk from the Campania region (Italy): Decreasing trend and baseline assessment over 10 years (2008–2018)
- 1 November 2021
- Published by Elsevier in Science of The Total Environment
- Vol. 794, 148504
Dioxins and dioxin-like PCBs in buffalo milk from the Campania region (Italy): Decreasing trend and baseline assessment over 10 years (2008–2018)
- 1 January 2021
- Published by Elsevier in Chemosphere
- Vol. 263, 128226
Polychlorinated organic pollutants (PCDD/Fs and DL-PCBs) in loggerhead (Caretta caretta) and green (Chelonia mydas) turtles from Central-Southern Tyrrhenian Sea
- 1 January 2021
- Published by Elsevier in Chemosphere
- Vol. 263, 128226
Polychlorinated organic pollutants (PCDD/Fs and DL-PCBs) in loggerhead (Caretta caretta) and green (Chelonia mydas) turtles from Central-Southern Tyrrhenian Sea